NEW YORK, Oct. 9 - Genaissance Pharmaceuticals has licensed certain data from its haplotype library to drug giant Pfizer, Genaissance said on Tuesday.

Financial terms of the deal were not disclosed.

Genaissance, based in New Haven, Conn., has already identified roughly 80,000 haplotypes from almost 5,000 genes and says it intends to discover haplotypes across the entire genome.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.